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Abstract - Objective : The aim of this 
study was to describe the use of equine 
pericardium sheet (Lyomesh
®
) as dural substitute 
for sellar reconstruction after endoscopic 
endonasal transsphenoidal surgery for the removal 
of pituitary adenomas. 
Methods : We reviewed data of patients 
that underwent surgery by means of an endoscopic 
endonasal transsphenoidal approach for the 
removal of pituitary adenomas over a 12-months 
period, starting in May 2012, i.e. when we adopted 
Lyomesh
®
 (Audio Technologies, Piacenza, Italy) 
an equine pericardium sheet, as dura mater 
substitute. 
 
Results: During the 12-months period 
evaluated, we performed an endoscopic endonasal 
transsphenoidal operation for a variety of pituitary 
lesions on 102 consecutive patients. Among these, 
in 12 patients (9.4%) harboring a pituitary 
adenoma, the implant of the pericardium sheet was 
used. Four patients (33.3%) presented a small 
intraoperative cerebrospinal fluid (CSF) leak; in 
these cases the Lyomesh
®
 was placed intradurally 
with fibrin glue and, thereafter, several layers were 
positioned in extradural space. In 8 other subjects 
without any evidence of CSF leak, the dural 
substitute was placed intradurally and fibrin glue 
was injected intradurally to hold the material in 
place.  
 
Conclusions: Even if based on a relatively 
small patient series, our experience demonstrated 
that the use of equine pericardium sheet 
(Lyomesh
®
) as dura mater substitute in 
transsphenoidal surgery is safe and biocompatible, 
as compared with other dural substitutes. 
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The widespread use of the endoscopic techniques has 
widened the possibilities of the transsphenoidal surgery, 
providing access to several areas of the skull base. 
Notwithstanding a consistent number of advantages, 
still there are several drawbacks, among those the 
postoperative CSF leakage. It  has to be minded that this 
risk is different between so called “standard” 
procedures, targeted to the sellar area and the 
“extended” procedures, targeted mostly to the whole 
midline sku ll base. Indeed, in recent series reporting 
outcomes of the transsphenoidal approach, either 
endoscopic or microscopic, for the removal o f sellar or 
intra-suprasellar in fradiaphragmatic lesions, the rate of 
postoperative CSF leak is low, ranging from 0% to 
5.1%; on the other side, in the so called “extended” 
procedures this rate is higher, ranging from 0% to 21% 
[1-12]. Several d ifferent prediction factors have been 
identified, such as elevated BMI (body mass index) that 
could directly correlate with the occurrence of CSF 
leakage [13], although it stands clear that the ineffective 
repair of an intraoperative CSF fistula could be assumed 
as the major cause of such postoperative complications. 
Furthermore, the postoperative CSF leakage, if 
untreated, could create a direct communicat ion between 
nasal cavities, and the brain, thus resulting in meningitis 
[2, 6, 14, 15].  As well, the loss of CSF could lead to a 
tension pneumocephalus, representing another 
potentially devastating complicat ion of this type of 
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surgery, occurring with lower rates, usually lesser than 
0.5% [16-18].  
Therefore, in recent years, different sellar and skull base 
reconstruction techniques have been described, 
accounting on an extreme variety of strategies and 
materials, i.e. autologous, heterologous and synthetic. 
There is not a univocal consensus concerning the best 
reconstruction option and strategies and materials 
should be tailored according to every single case.  
The use of autologous materials (fat, muscle, fascia 
lata) might be preferred, because they are vital and do 
not engender any immune and/or inflammatory 
response. However, many of these substances require a 
separate surgical incision, either on the abdomen or on 
the thigh. With the modern min imally invasive 
conceptual way  of thinking and the reduction of 
morbidity and mortality, the patients’ requests are leant 
toward the avoidance of a second skin incision. For 
these reasons, and for the possibilities offered by these 
products of reliable sterility, the use of non-autologous 
dural substitutes, both heterologous and synthetic, has 
received a tremendous boost. In this environment, 
pericardium-based heterologous products are becoming 
increasingly popular. Lyomesh
®
 (Audio Technologies, 
Piacenza, Italy) is an equine pericardium membrane, 
used as dural substitute, recently introduced in the 
market; it is made of polypeptides chains, forming the 
elementary fibers, interwoven and shaped as cords, then 
anastomosed in complanate networks.  
The aim of this study is to evaluate the safety and the 
effectiveness of this material for sellar reconstruction 
after a standard endoscopic endonasal approach for the 
removal of a pituitary adenoma. 
 
 




We retrieved data from the analysis of 102 patients that 
underwent surgery for p ituitary lesions, from May 2012 
to May 2013. 
The Lyomesh
®
 dural foil was used in 12 cases 
harboring a pituitary adenoma: in four o f them it was 
adopted to repair an intraoperative CSF leakage - grade 
I according to Kelly’s paradigm -, whereas in eight 
cases to protect a thinned suprasellar cistern - grade 0 
according to Kelly’s paradigm [19] -.  
We reported the use of such dural substitute in three 
PRL-secreting macroadenomas, two ACTH–secreting 
macroadenomas and seven non-functioning 
macroadenomas.  
There were five males and seven females (mean age 
52.5, ranging from 35 to 70 years). The postoperative 
follow-up ranged from 3 to 12 months. 
The technique of reconstruction was different according 
to the entity of leakage to the anatomical and/or lesion 
features. 
All patients underwent a three months postoperative 
endoscopic endonasal exp loration of the sino-nasal 








All patients underwent surgery by means of an 
endoscopic endonasal approach to sellar region for the 
removal of a p ituitary adenoma, according to technique 
already described in the main literature [20-27]. 
For the reconstruction phase of the standard procedure, 
we usually don’t harvest any autologous material such 
as abdominal fat graft or fascia lata, nor remove the 
middle turbinate to be used as free mucoperichondrium 
flap.    
In case of small intraoperative CSF weeping leak (grade 
I) or also to protect a thinner and/or prolapsed 
suprasellar cistern (grade 0) [19], we performed the 
repair of the osteodural defect by mean of different 
techniques after tumor removal. The Lyomesh
®
 foil was 
placed intradurally in  the eight cases presenting a CSF 
leak grade 0, when the suprasellar cistern was intact, 
prolapsed into the sellar cavity but thinner; fibrin glue 
was injected intradurally to hold the material in place.  
In four cases with grade 1 intraoperative CSF leak, a 
single layer of Lyomesh
®
 was placed intradurally with 
fibrin g lue and, thereafter, several layers were 
positioned in the extradural space to ensure the 
watertighteness.  
In two cases of this latter group the sphenoid sinus was 
filled with fibrin glue. 
Manufacture and handling of the collagen foil 
Lyomesh
®
 is a processed equine pericardium 
deproteinized with enzymatic method that preserves 
only purified co llageneous network. The pericardium 
foil is made up of complanate multi-layer networks, 
rendered thinner by machinery process. Before its use 
the dural substitute must be washed at least 10 minutes 
in 50cc physiological saline solution. A full load of 





There were two main reasons that required the use of 
the dural substitute: the first one was an intraoperative 
CSF leak (grade I according to Kelly [19] - occurred in 
four cases -, while the second one was the prolapse of 
an intact, thinner suprasellar cistern after tumor removal 
- occurred in eight cases -.  
When intraoperative CSF leak was evident, the dural 
substitute was directly placed over the leaking points 
and intrasellar fibrin glue was in jected [1, 28]; multiple 
layers of Lyomesh
®
 were positioned in the extradural 
space to complete the repair o f the osteo-dural defect 
(Fig. 1). 
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Fig 1. a: Intraoperative image showing a thinned  suprasellar cistern 
descending into the sellar cavity after the removal of a pituitary 
adenoma; b: a pericardium sheet was used to protect and enforce the 
suprasellar cistern and prevent its postoperative rupture and 
consequent CSF leak; c, d: multiple layers of dural substitute placed 
in extradural space to close the sellar floor   
*: single layer of Lyomesh® placed intradurally, over the Suprasellar 
Cistern; **: Lyomesh® placed extradurally; SC: suprasellar cistern.  
 
 
When there was not any evidence of CSF leak, the 
pericardium sheet was placed over the suprasellar 
cistern and then supported by the intrasellar in jection of 
fibrin g lue [1, 28]. Three months MRI postoperative 
endoscopic control and sellar MRi showed the complete 
integration of the dural substitute (Fig. 2) 
 
 
Fig 2. Preoperative and postoperative sellar MRi of a patient with an 
intra-suprasellar non-functioning pituitary adenoma, who received the 
implant of Lyomesh
®
.Preoprative (a)coronal and (b) sagittal scans. 
Postoperative (c) coronal and (d) sagittal scans showing no direct or 





We did not observe any adverse clinical reactions 
directly related with the use of the dural substitute or 
any post- operative CSF leak (see Table I).  
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TABLE I. PATIENT POPULATION AND SELLAR RECONSTRUCTION TECHNIQUE. 
No. Age/Sex Adenoma type  CSF leak grade  
Sellar reconstruction technique  
Lyomesh
® 
position Fibrin glue  
1 35, F NF 0 Intradural space sellar cavity 
2 37, M Prl-sec 1 Intradural/extradural space sellar and sphenoid sinus cavities 
3 40, F Acth-sec 0 Intradural space sellar cavity 
4 45, M NF 0 Intradural space sellar cavity 
5 47, F Prl-sec 1 Intradural/extradural space sellar cavity 
6 50, F Acth-sec 0 Intradural space sellar cavity 
7 55, M Prl-sec 0 Intradural space sellar cavity 
8 58, F NF 1 Intradural/extradural space sellar and sphedoid sinus cavities 
9 60, F NF 1 Intradural/extradural space sellar cavity 
10 65, M NF 0 Intradural space sellar cavity 
11 68, F NF 0 Intradural space sellar cavity 




Traditional reconstruction techniques used in 
transcranial surgery, such as dural suturing and bone 
flap  fixat ion, are not feasible after transsphenoidal 
surgery so that the osteo-dural reconstruction represents 
a main issue of this kind of surgery, often resulting 
troublesome. Sellar reconstruction after transsphenoidal 
pituitary tumor removal it is not mandatory in all cases 
but it is necessary in case of intra-operative CSF 
leakage or in presence of conditions that potentially 
expose to such event, such as the prolapse of suprasellar 
cistern into the sellar cavity [1, 28].  
Although autologous materials (fat, muscle, fascia lata) 
might be preferred because of their biocompatibility and 
the lesser risk o f immune or inflammatory response, 
they are harvested through a separate surgical incision, 
either on the abdomen or on the thigh that prolongs the  
surgical times and could be aesthetically disfiguring. On 
the other hand, it has to be said that, during endoscopic  
endonasal surgery, autologous materials could be 
harvested from the nasal structures i.e. middle turbinate 
and/or septal mucosa.  
Heterologous materials, conversely, should be preferred 
to the synthetic ones because they are not absorbable 
and their inertness is still not absolute, with the 




 has never been studied before for the use in 
this type of surgery. Thanks to the data collected along 
our series we have drawn some considerations in 
regards:  
1. Watertightness: it provides a fluid-tight barrier 
against CSF leakage;  
2. safety and biocompatibility: differently from 
bovine-derived dural substitute, this one is 
taken from horse, the only  animal BSE safe, so 
there is no risk of infection transmission to 
human. It  is bio logically tested, non cytotoxic, 
non sensitizing, non mutageneous, with zero 
intracutaneous reactivity. The device is  
biocompatible and releases molecules that are 
metabolized without flogistic response. 
Nevertheless it should be used in patients 
allergic to horse meat; 
3. easiness to handle: can be molded and shaped 
according to different needs of the repairs; 
4. transparency: the transparency of Lyomesh® 
enables the surgeon to optimally inspect the 
underlying tissues; 
5. mechanical resistance: the sheet traction and 
pressure resistance indexes are far higher than the 
one of the collagen tissues obtained through 
purification and artificial reticulat ion. Lyomesh
®
 
shows the mechanical resistance/thickness best 
ratio if compared with other b iologic tissues of 
animal orig in and to the artificial co llageneous 
sheets; 
6. slow resorption: it  remains unchanged while 
fibroblasts and endotelial cells enter it, acting 
as a guide for connective regeneration while it  
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is slowly digested and replaced by  autologous 
connective tissue. 
Since no previous studies are currently availab le to 
assess its security and effectiveness in transsphenoidal 
pituitary surgery, we used this new dural substitute only 
in cases of small CSF weeping, to protect the 
suprasellar cistern after the tumor removal or to close 
the sellar floor. 
In fact, especially in cases of large or invasive 
adenomas, the suprasellar arachnoidal membrane could 
be thinned and the diaphragma sellae could be 
incompetent: even if there is not intraoperative evidence 
of CSF leak, this latter may occur later. Therefore, in 
these cases, the graft was kept in place by the sole fibrin 
glue that has proven in preliminary studies to be 
sufficient for this purpose [28-30].  
Due to the limited experience we would not yet 
recommend this material as sole substitute in case of 
large intraoperative CSF leak. In these cases, we 
followed the paradigm of graded sellar repair with 
multip le materials, combined to seal the d ifferent 




Our preliminary results, even on a small patient series, 
demonstrate that the pericardium sheet, i.e. the 
Lyomesh
®
, presents advantages at least comparable 
with prev ious studies on similar materials [31]: it  is 
safe, it is easy to handle and it is effect ive as dural 
substitute for the standard endoscopic procedures for 
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